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A b S T R A C T
Background: The use of electrocardiography (ECG) is a practical method to evaluate the response to 
cardiac resynchronization therapy (CRT) implantation, as it is easily performed and saves time.
Aim: This study aimed to assess the predictive value of the T-wave duration and Tpeak-Tend (Tp-e) 
interval following the CRT implantation administered to heart failure patients.
Methods: Sixty-seven patients with left ventricular ejection fraction ≤35, New York Heart Association 
(NYHA) class II–III, ambulatory class IV, normal sinus rhythm, who have complete left bundle branch 
block on ECG and treated with CRT were included in this study. Patients who have manifested a ≥10% 
improvement in ejection fraction following CRT implantation, were categorized as “responders”, and the 
remaining patients were categorized as “non-responders”. ECGs and echocardiograms were evaluated 
both six months before and after CRT implantation. 
Results: The post-CRT QRS duration (P = 0.01), cQT interval (P = 0.005), T-wave (P <0.001), and Tp-e 
interval (P <0.001) were found to be significantly reduced in the responder group compared to the 
non-responder group. The receiver operating characteristics curve analyses revealed that the predictive 
optimal cut-off of the T-wave was <182 ms (P <0.001), and that of the Tp-e interval was <92 ms (P <0.001).
Conclusions: T-wave and Tp-e interval may be independent predictors of a favorable CRT response in 
heart failure patients.
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IntRoduCtIon
Heart failure with reduced ejection fraction (HFrEF) is 
a syndrome that is still associated with high mortality 
and morbidity rates, despite the advancements in the 
relevant diagnostic and therapeutic methods [1]. The 
mortality rate of the patients admitted to the hospital with 
the said diagnosis is approximately 20%, which goes up 
as high as 40% in patients over the age of 75 despite the 
administration of medical treatments [2]. The V-Heft (Vet-
erans Heart Failure Trial) study revealed that the average 
life expectancy in HF patients receiving pharmacological 
treatment was 3.5 years [3], whereas the CARE-HF (Cardiac 
Resynchronisation in Heart Failure) study revealed that the 
addition of cardiac resynchronization therapy (CRT) to the 
treatment increased the average life expectancy by more 
than 8 years [2–4].
CRT improves the symptoms of HFrEF patients by re-
ducing the prolonged conduction time, accelerating the 
myocardial contraction duration, and decreasing mitral 
regurgitation [2]. However, this response is not observed 
in all HFrEF patients that undergo CRT, and unfortunately, 
an adverse clinical course may be experienced in some 
patients. The favorable predictors of CRT responders are still 
a matter of investigation. Following the CRT implantation, 
narrowing of the QRS duration and the QT interval are 
known to be effective prognostic markers. However, only 
a limited number of studies available in the literature on the 
relationship between the post-implantation CRT response 
and T-wave and Tpeak-Tend (Tp-e) interval. Therefore, this 
study aimed to investigate the predictive value of T-wave 
and Tp-e interval in patients with HFrEF and left bundle 
branch block (LBBB) and who underwent CRT implantation.
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W H A T ’ S  N E W ?
This study revealed that narrowing of Tpeak-Tend interval following the cardiac resynchronization therapy (CRT) implantation 
is associated with favorable response to CRT implantation and has predictive potency in the same range as QRS duration and 
QT interval, paving the way for the use of electrocardiography to easily evaluate the response to CRT implantation in daily 
clinical practice without the need for complex computer programs and other imaging tools.
MEtHodS
Study population
A total of 72 consecutive patients were admitted to the 
hospital between January 2017 and February 2020 with 
HFrEF ([left ventricular ejection fraction (LVEF) ≤35], New 
York Heart Association [NYHA] class II–III, ambulatory class 
IV, normal sinus rhythm) and complete LBBB (QRS ≥ 120 ms) 
was included in the study. Five of these patients were 
excluded from the study since they have developed atrial 
fibrillation during the follow-up. Demographic and clinical, 
laboratory data of patients were accessed from their medi-
cal records. All the patients received optimal HFrEF treat-
ment dosage (angiotensin-converting enzyme inhibitors 
or angiotensin receptor blockers [ACEI/ARB], acetylsalicylic 
acid [ASA], ivabradine, β-blockers, mineralocorticoid anta-
gonists, and loop diuretics).
Patients were categorized as “responders” and 
“non-responders” on the basis of the LVEF values, as per the 
previously published studies. A “responder” was described 
as a patient with an absolute LVEF recovery ≥of 10% as de-
monstrated by echocardiography six months after the CRT 
implantation, whereas a “non-responder” was described 
as any patient who did not meet the above-mentioned 
criterion [5, 6].
The exclusion criteria were as follows; revascularizati-
on due to acute coronary syndrome in the last 6 months, 
severe mitral and aortic valve diseases, development of 
atrial fibrillation, having undergone dialysis, cardiorenal 
syndrome, severe right heart failure, and development of 
ischemic hepatitis.
Ethics committee approval (no: 116.2017.178, date: July 
2, 2020) was obtained from the Non-Interventional Clinical 
Research Ethics Committee of Istanbul Süreyyapasa Chest 
Disease and Chest Surgery Training and Research Hospital, 
before the initiation of the study. Written and verbal con-
sents were obtained from all participants. Declaration of 
Helsinki was followed in  the ethical principles of the study. 
CRT device implantation 
CRT devices (Boston Scientific, Natick, MA, USA) were 
placed in all patients by experienced electrophysiologists 
in accordance with current guidelines [1, 2]. The right 
atrial lead was inserted in the right atrium appendix, left 
ventricular lead was placed in the posterolateral coronary 
sinus vein, and right ventricular lead was implanted in the 
septal regions of the right ventricle. 
Electrocardiography 
All patients received 12-lead electrocardiography 
(ECG) in the supine position after resting for at least 
15 minutes (GE MAC 1200, USA). Each ECG was ta-
ken at a paper rate of 25 mm/s, a gain of 10 mV, and 
a paper report format of 4 × 2.5R1. Before and after the 
CRT implantation ECG was interpreted by two different 
cardiologists independently. Patients that have met strict 
LBBB criteria (QS or rS in leads V1 and V2, and mid-QRS 
notching/slurring in ≥ 2 out of leads V1, 2, 5, 6, I and aVL, 
QRS duration ≥140 ms [men] or ≥130 ms [women]) were 
included in the study [7]. QRS duration was described as 
the time interval from the onset to the end of the QRS 
complex (Figure 1). Paced QRS duration was measured 
after CRT implantation from the peak to the end of the 
QRS complex (Figure 2). QT interval was measured from 
the onset of the QRS complex to the end of the T-wave 
(Figure 1). The QTc (corrected QT) interval was measured 
using Bazett’s formula [8]. T-wave duration was described 
as the time interval from the onset to the end of the T-wave 
(Figure 1). The interval from the peak of the T-wave to the 
end of the T-wave was denoted as the Tp-e interval (Figure 
3). The peak of the T-wave was defined as the maximum 
positive or the maximum negative amplitude taking the 
isoelectric line as the reference. The end of the T-wave 
was described as the intersection of the tangent with the 
descending part of the T-wave and the isoelectric line [9] 
(Figure 3). The QRS, T-wave and Tp-e interval values were 
obtained from the average of all precordial leads as exactly 
observed on the ECG [9].
Echocardiography
Echocardiography was performed in all patients within 
one week before and six months after CRT implantation. 
In accordance with the recommendations of the American 
Society of Echocardiography, all patients underwent a tran-
sthoracic echocardiographic examination with a commer-
cially available device using 4 MHz probes (Vivid 9 Pro, GE 
Vingmed, Milwaukee, WI, USA) in the left lateral decubitus 
position [10]. All conventional measurements were per-
formed on the parasternal long-axis and apical four-chamber 
views. LVEF was calculated by Simpson’s method [10].
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Figure 1. The illustrations of ventricular depolarization and repolarization duration on an electrocardiographic example



















Posteroanterior and lateral chest radiographs were taken 
for the location of the right and left ventricle leads after 
CRT implantation. The right ventricular lead was placed 
in the apical regions of the right ventricle in all patients. 
Follow-up
All patients were followed by their cardiologists over the 
phone or in-person during their hospital visits. During the 
follow-up, their heart rhythm and functional capacity data 
as well as their ECGs and echocardiograms were recorded. 
The deaths of the patients who died during the follow-up 
period were investigated as to whether the deaths were 
due to a cardiovascular cause, and the relevant finding was 
included in the patient records.
Statistical analysis 
Statistical analysis was performed using Statistical Package 
for the Social Sciences (SPSS) version 20.0 (IBM Corporation, 
Armonk, NY, USA) software package. Continuous variables 
were expressed as mean standard deviation (SD) values 
or median interval interquartile (IQR) values, whereas 
categorical variables were expressed as proportions. Sha-
piro-Wilk and Kolmogorov-Smirnov tests were performed 
to determine whether the research data had conformed 
to normal distribution. The baseline characteristics of the 
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CRT patients were compared using the student’s t-test 
for continuous variables and normal distribution and the 
χ2 Pearson’s test for categorical variables. In cases where 
it was found that the data were not distributed normally, 
Mann-Whitney U test was used to compare the two in-
dependent groups. Univariable analysis was performed 
to identify potential risk factors for responder CRT. Mul-
tivariable logistic regression analysis was performed to 
determine independent predictors of responder CRT [11, 
12]. The receiver operating characteristics (ROC) curve 
analysis was used to evaluate the optimal cut-off of the 
QRS, QT, T-wave and Tp-e interval prediction model for CRT 
responder. A 2-tailed P-value below 0.05 was considered to 
be significant in all statistical analyses performed.
RESultS
The mean (SD) age of patients was  63.5 (10.0) years, most 
of the patients were men (n = 44, 65.7%), and had non-is-
chemic cardiomyopathy (74.2%). The  median follow-up 
duration was  32 (IQR 9–41) months. The mean (SD) ejection 
fraction of pre-implantation and post-implantation were 
found to be 28.2(4.3)% and 38.9(6.8)%, respectively. In ac-
cordance with the recommendations set forth in the most 
recent guidelines, patients were determined to have used 
ACEI/ARB (95.5%) and β-blockers (92.5%). The majority of 
patients admitted to the hospital were those diagnosed 
with NYHA class III (59.7%), class II (26.8%), and class IV 
(13.4%) (Table 1).
No significant difference was found between the re-
sponder and non-responder groups in terms of age, body 
mass index, hypertension, diabetes mellitus, medications 
taken, and duration of follow-up period. There was no 
difference between the two groups in terms of pre-im-
Figure 3. An example of the measurement of Tpeak-Tend interval from 12‐lead surface electrocardiography
plantation ECG parameters, such as heart rate, P duration, 
PR interval, QRS duration, QT interval, cQT interval, T-wave, 
and Tp-e interval (Table 2).
The percentage of females (45.9% vs 6.0%; P = 0.02), 
and  the number of NYHA class III patients (64.8% vs 53.3%; 
P =0.01, respectively) were higher in the CRT responder 
group (Table 1).
Furthermore, post–implantation mean (SD) QRS 
duration (143.3 [18.6] vs 160.1 [29.2] ms; P = 0.01), QTc 
interval (474.8 [43.4] vs 502.7 [49.6] ms; P = 0.005), T-wave 
(165.6 [25.7] vs 192.1 [25.0] ms; P <0.001 ) and Tp-e interval 
(82.9 [13.2] vs 98.1 [13.3] ms; P <0.001) values were found 
to be substantially shorter in the CRT-responder group 
(Table 2).
The univariable regression analyses were revealed that 
shortening of QRS duration (OR, 0.976; 95% CI, 0.958–0.995; 
P = 0.01), cQT interval (OR, 0.983; 95% CI, 0.971–0.996; 
P = 0.01), T-wave duration (OR, 0.952; 95% CI, 0.928–0.976; 
P <0.001), and Tp-e interval (OR, 0.905; 95% CI, 0.860–0.952; 
P <0.001) was a potential risk factors for the CRT response, 
whereas multivariable logistic regression analysis was 
revealed that only the reduced Tp-e interval was the inde-
pendent predictor of the CRT-response (Table 3).
The ROC analysis revealed that the optimal cut-off value 
of the Tp-e interval was <92 ms, with 80% sensitivity and 
79% specificity (AUC, 0.82; 95% CI, 0.725–0.926; P <0.001) 
(Figure 4).
dISCuSSIon
In this study, it was found that the QRS duration, QT inter-
val, T-wave duration, and Tp-e interval were significantly 
reduced in those who responded to CRT implantation. 
In addition, patients with NYHA class III and of female 
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Age, years, mean (SD) 63.5 (10.0) 61.8 (10.4) 66.2 (8.9) 0.06
Female gender, n (%) 23 (34.3) 17 (45.9) 6 (20.0) 0.02
BMI, kg/m2, mean (SD) 29.5 (14.5) 28.2 (15.6) 29.8 (13.8) 0.35
Hypertension, n (%) 26 (38.8) 15 (40.5) 11 (36.6) 0.78
Diabetes mellitus, n (%) 14 (20.9) 8 (21.6) 6 (20.0) 0.49
Ischemic CMP, n (%) 24 (35.8) 11 (29.7) 13 (43.3) 0.24
Follow-up, months, median (IQR) 32 (9–41) 33 (7-45) 20 (7–44) 0.06
Preimplantation LVEF, %, mean (SD) 28.2 (4.3) 28.9 (4.1) 27.4 (4.4) 0.15
Post implantation LVEF, %, mean (SD) 38.9( 6.8) 40.5 (5.1) 28.0 (7.5) <0.001
Pharmacological therapy
ACEI/ARB, n (%) 64 (95.5) 36 (97.2) 28 (93.3) 0.38
Beta-blockers, n (%) 62 (92.5) 35 (95.6) 27 (90.0) 0.24
Loop diuretics, n (%) 50 (74.6) 28 (75.6) 22 (73.3) 0.93
Aldesterone antagonist, n (%) 15 (22.3) 9 (24.3) 6 (20.0) 0.73
ASA, n (%) 29 (43.2) 15 (40.5) 14 (46.6) 0.67
Ivabradine, n (%) 19 (28.3) 11 (29.7) 8 (26.7) 0.62
NYHA class, n (%)
Class II 18 (26.8) 9 (24.3) 9 (30.0) 0.01
Class III 40 (59.7) 24 (64.8) 16 (53.3)
Class IV 9 (13.4) 4 (10.8) 5 (16.6 )
Quantitative variable was presented as mean (SD) and median (IQR).
Abbreviations: ACEI/ARB, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers; ASA, acetylsalicylic acid; BMI, body mass ındex; CMP, cardiomyopathy; 
LVEF, left ventricular ejection fraction; NYHA, New York Heart Association









Pre CRT ECG parameters
Heart rate, bpm 73.1 (15.1) 72.0 (15.8) 75.3 (13.8) 0.45
P duration, ms 96.4 (16.0) 93.8 (17.3) 101.5 (11.9) 0.09
PR interval, ms 178.3 (46.4) 177.4 (42.9) 181.5 (52.9) 0.75
QRS duration, ms 151.5 (18.8) 150.5 (18.1) 153.6 (12.9) 0.51
QT interval, ms 441 (46.7) 449.2 (52.8) 433.5 (43.7) 0.07
cQT interval, ms 481.2 (33.4) 482.7 (32.6) 478.5 (35.7) 0.66
T-wave duration, ms 193.6 (30.6) 197.9 (31.9) 185.1 (26.7) 0.14
Tp-e interval, ms 96.5 (15.4) 100.9 (16.9) 93.3 (14.8) 0.10
Post CRT ECG parameters
Heart rate, bpm 78.4 (14.9) 76.8 (15.7) 81.2 (14.6) 0.31
P duration, ms 91.6 (14.4) 89.3 (13.4) 93.1 (16.3) 0.37
PR interval, ms 138.6 (28.2) 141.0 (26.8) 134.8 (27.7) 0.42
QRS duration, ms 155.6 (27.2) 143.3 (18.6) 160.1 (29.2) 0.01
QT interval, ms 438.6 (48.2) 432.7 (47.2) 448.7 (49.4) 0.18
cQT interval, ms 488.4 (45.9) 474.8 (43.4) 502.7 (49.6) 0.005
T-wave duration, ms 179.5 (24.7) 165.6 (25.7) 192.1 (25.0) <0.001
Tp-e interval, ms 88.9 (13.1) 82.9 (13.2) 98.1 (13.3) <0.001
The distribution of quantitative variable was presented as mean (SD). 
Abbreviations: CRT, cardiac resynchronization therapy; Tp-e, Tpeak to Tend interval
gender demonstrated predominantly favorable response 
to the CRT.
The objective of CRT is to reduce the cardiac conduc-
tion time, normalizing the duration of depolarization and 
repolarization and providing effective myocardial contrac-
tions as a result. In the light of the data reported in the 
Comparison of Medical Therapy, Pacing, and Defibrillation 
in Heart Failure (COMPANION) and CARE-HF studies, CRT 
significantly reduces all-cause mortality or hospitalization 
in patients with an HFrEF (LVEF ≤35) and a QRS duration of 
≥150 ms [4, 11]. Along the same lines, it was demonstrated 
in many studies that reduced QT and QTc intervals following 
CRT implantation have been associated with improved 
LVEF and decreased mortality and morbidity in patients 
with HFrEF [4, 13–15]. Similarly, in this study, the QRS du-
ration was found to have been shortened in patients with 
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complex measurement methods need special computer 
programs and are difficult to be performed during the 
daily clinical practice when evaluating the CRT response 
at the bedside. Hence, the aim of this study has been to 
come up with a method that can be easily measured and 
does not take much time, and which is as accurate and 
precise as the shortening of QRS duration as a predictor. In 
conclusion, significant results were achieved with regards 
to T-wave duration and Tp-e interval, as easily measurable 
predictors of CRT response. 
Different types of cells in the myocardium such as 
epicardial, endocardial, and M cells take part in the gene-
ration of the T-wave, which is an indicator of ventricular 
repolarization. Complete repolarization of epicardial cells 
concurred with the peak of the T-wave, while repolarization 
of M cells complied with the end of the T-wave. Tp-e interval 
shows transmural repolarization (TMR), which corresponds 
to the last part of repolarization [20]. 
In patients with HF and LBBB, structural changes in 
myocardial cells (remodeling in calcium and ion channels, 
increases in fibrosis and myocardial cell volume changes) 
cause both electrical and mechanical desynchronization 
and prolong the depolarization and repolarization pro-
cess. Prolonged duration of repolarization may result in 
worsening of HF through impaired cardiac relaxation. 
The objective of CRT implantation is to provide cardiac 
conduction within normal physiological limits with bi-
ventricular pacing. CRT assists the myocardial contraction 
and relaxation functions of the heart via subendocardial 
stimulation through right ventricular pacing and simul-
taneous epicardial stimulation with the left ventricular 
lead. In subjects without structural heart disease, the 
pacemaker causes a significant increase in the depolari-
zation-repolarization process. In this context, Fuenmajor 
et al. have demonstrated that in subjects without heart 
disease, there was no difference in pacemakers compared 
to the right or left univentricular pacing, however that 
biventricular stimulation produced less variation in the 
depolarization-repolarization process [21]. Furthermore, 
a meta-analysis by Duan et al. revealed that biventricular 
pacing did not disturb repolarization functions, and it was 
only the left ventricular pacing that prolonged the Tp-e 
table 3. The association between cardiac resynchronization therapy responders and electrocardiographic parameters with logistic regres-
sion analysis 
Variables  univarable analysis  Multivariable analysis
 oR (95% CI) P-value oR (95% CI) P-value
Female gender 3.40 (1.127–1.253) 0.03
PI LVEF, % 1.50 (1.052–2.351) 0.02
NYHA class III 0.43 (0.104–1.819) 0.25
PI QRS duration 0.97 (0.958–0.995) 0.01
PI cQT interval 0.98 (0.971–0.996) 0.01
PI T-wave duration 0.95 (0.928–0.976) <0.001
PI Tp-e interval 0.90 (0.860–0.952) <0.001 0.90 (0.860–0.952) <0.001
Abbreviations: PI, post implantation; other abbreviations: see Table 1 and 2
CRT-response, and particularly in those with a QRS duration 
below 149 ms and with better outcomes. In sum, shortened 
QRS duration is currently a widely accepted marker in the 
determination of a favorable CRT-response [16, 17].
The main objective of this study was to investigate 
whether the use of repolarization shortening can be as 
effective as the use of depolarization shortening. For this 
reason, the T-wave and Tp-e interval, easily measurable 
ECG parameters, were taken into consideration. Despite 
the fact that there is no certain evidence that the increased 
T-wave duration implies an unfavorable CRT response, it 
was reported in the literature that the T-wave area and 
its morphology have been associated with prognosis in 
patients with HFrEF who underwent CRT [18, 19]. In ad-
dition, new measurement methods that utilize automatic 
ECG programs such as absolute T-wave residuum, T-wave 
morphology dispersion and T-wave loop area, are effective 
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Figure 4. Receiver operating characteristic (ROC) curves for detec-
ting patients with favourable responders to cardiac resynchroniza-
tion therapy, the optimal cut-off Tpeak-Tend interval was <92 ms, 
with 80% sensitivity, 79% specificity and the area under the curve 
(AUC) of 0.82 (95% CI, 0.725–0.926; P <0.001)
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interval in patients with heart failure and who underwent 
CRT implantation [22]. Engels et al. demonstrated that in 
patients with LBBB morphology, a larger baseline T-wave 
area is a significant independent predictor of LVEF increa-
se following CRT [18]. Huang et al. demonstrated that HF 
patients with LBBB, larger T-wave morphology dispersion, 
larger T-wave loop area, and more negative QRS-to-T ang-
le had a better echocardiographic response to CRT [19]. 
Flore et al. found that the absence of any changes in QRS 
duration and broader electrical remodeling (including the 
measurements of the angles between spatial QRS and T 
vectors before, during, and after CRT) are associated with 
notably better survival rates [23]. 
The common point of all the aforementioned studies is 
that the favorable effects of biventricular pacing on repola-
rization duration were implied in all, whereas in the study by 
Medina-Ravel et al. the QT and JT intervals reflecting repo-
larization were found to be longer in biventricular and left 
ventricular pacing compared to right ventricular pacing [24].
To sum up, CRT mimics normal cardiac physiology 
by biventricular pacing, providing the improvement of 
depolarization and repolarization time, which reflects the 
contraction and relaxation function of the heart, thereby 
increasing the functional capacity and improving LVEF in 
the patient with heart failure. In most of the above-menti-
oned studies as well as in this study, the favorable response 
to CRT implantation was evaluated on the basis of whether 
there was an increase in LVEF or not.
One of the important findings of this study was 
female gender had a higher rate of favorable response 
to CRT. The results were comparable to those reported 
in the Multicenter Automatic Defibrillator Implantation 
Trial — Cardiac Resynchronization Therapy (MADIT-CRT) 
trial [25]. All patients included in our study had LBBB and 
the majority of the female patients had a favorable CRT 
response, which  supports the results of the previously 
published studies. Another outcome  of this study was that 
the NYHA class III patients were found to have benefited 
more from CRT treatment, which is a comparable result to 
those reported in the MADIT, CARE-HF, COMPANION and 
AL-FINE CRT risk score studies [4, 13, 25–27].
Nevertheless, it is still not yet clear why only a certain 
number of patients were found to have benefited from CRT 
while others of similar characteristics have not. The fact that 
the heart construction and the electrophysiological condu-
ction is different in every patient, irrespective of whether 
the patients had any structural heart disease or not, as well 
as any unidentified molecular or genetic differences might 
have affected the CRT response.
In this study, the importance of the background T-wave 
and Tp-e interval has been emphasized in assessing the CRT 
response. Normalization of the myocardial relaxation time 
as well as of the myocardial contraction is an important 
step in determining the response to CRT implantation. 
However, it may not be the right approach to arrive at 
a conclusion about the CRT response just based on the 
ECG parameters. Nevertheless, ECG is a very practical and 
simple method, and it does not take up much time in daily 
clinical practices.
Limitations 
The first and foremost limitation of this study was that it 
was carried out as a single-center and retrospective study. 
Secondly, the number of patients included in the study was 
limited as only the patients with normal sinus rhythm and 
LBBB could be included in the study in order to achieve 
homogenization. Thus, the results of this study cannot be 
generalized to all patients with heart failure. In this study, 
an increase in LVEF values demonstrated by echocardi-
ography was deemed to be the sign for a favorable CRT 
response. Another advanced technology such as cardiac 
magnetic resonance imaging (MRI) may also be employed 
to assess the CRT response in addition to echocardiograph-
ic imaging.
ConCluSIon
In conclusion, the current study shows that the Tp-e interval 
is an independent predictor of a favorable CRT response in 
symptomatic patients with ischemic and nonischemic car-
diomyopathy. The use of T-wave duration and Tp-e interval 
together with QRS duration and QTc interval would prove 
to be useful in assessing favorable CRT response. 
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